[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369907-105":59,"doc-detail-369907-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","intratumoral-core-microbiota-predicts-prognosis-and-therapeutic-response-in-gastrointestinal-cancers","Intratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers","","Intratumoral microbial communities are positioned as a critical component of the tumor microenvironment in gastrointestinal cancers, yet their clinical value has been insufficiently studied. This research analyzes tumor microbiomes across six gastrointestinal cancer types and identifies a core set of 15 bacterial genera linked to patient prognosis. A microbiota-based risk-score model associates high-risk patients with worse survival, greater metastatic potential via EMT, angiogenesis, KRAS, and TGFβ signaling, and predicted sensitivity to XL999 and tandutinib. High-risk status also corresponds to reduced benefit from immunotherapy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/intratumoral-core-microbiota-predicts-prognosis-and-therapeutic-response-in-gastrointestinal-cancers/369907/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/intratumoral-core-microbiota-predicts-prognosis-and-therapeutic-response-in-gastrointestinal-cancers/369907.png","ImageObject",300,407,{"name":92,"@type":93},"Bulrr","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What core microbiota did the study identify in gastrointestinal cancers?","Question",{"text":113,"@type":114},"The study identifies a core microbiota composed of 15 bacterial genera associated with patient prognosis across six gastrointestinal cancer types.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the microbiota-based risk-score model work and what does it predict?",{"text":118,"@type":114},"Using bacterial abundance, the model calculates a risk score. High-risk scores predict poorer prognosis, enhanced metastatic potential, and pathway activation including EMT, angiogenesis, KRAS, and TGFβ signaling.",{"name":120,"@type":111,"acceptedAnswer":121},"Which treatments did the model suggest for high-risk patients, and how did microbiota relate to immunotherapy?",{"text":122,"@type":114},"The model predicts sensitivity to XL999 and tandutinib for high-risk patients. It also links microbiota composition to immunotherapy outcomes, with high-risk patients less likely to benefit from immunotherapy.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},369907,1790927527,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","| Open Peer Review | Clinical Microbiology | Research Article  \nIntratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers  \nJia Liu,1 Dongsheng Wei,1 Yue Chen,2 Xingzhong Liu1 AUTHOR AFFILIATIONS See affiliation list on p. 13.  \nABSTRACT Microbial communities residing in tumors constitute a critical component of the tumor microenvironment, particularly in gastrointestinal cancers arising from mucosal sites. However, the relationship between microbiota and oncogenesis, as well as its clinical applications, remains underexplored. Here, we performed a comprehensive analysis of the tumor microbiome across six gastrointestinal cancer types and identified a core microbiota composed of 15 bacterial genera associated with patient prognosis. Using bacterial abundance data, we developed a microbiota-based prognostic model to calculate a “risk score.” Patients with high-risk scores exhibited poorer prognosis and increased metastatic potential, driven by the activation of tumor metastasis-related signaling pathways, including epithelial-mesenchymal transition, angiogenesis, KRAS, and TGFβ signaling. Furthermore, the model predicted sensitivity to anti-cancer drugs, identifying XL999 and tandutinib as potential targeted therapies for high-risk patients.  \nThe core microbiota is also linked to host immunity; patients with high-risk scores were less likely to benefit from immunotherapy. Taken together, these findings highlight the potential of a microbiota-based prognostic model to enhance cancer diagnostics, inform therapeutic decision-making, and advance personalized medicine for gastrointestinal cancers.  \nIMPORTANCE Intratumoral microbiota influence cancer progression, yet their prognostic potential remains underutilized. This study identifies a core microbiota of 15 bacterial genera associated with survival in gastrointestinal cancers and develops a microbiotabased prognostic model. Unlike traditional gene-based models, this approach stratifies patients by microbial signatures, linking high-risk scores to enhanced metastasis via epithelial-mesenchymal transition, angiogenesis, and KRAS signaling. Additionally, we identify XL999 and tandutinib as potential therapies for high-risk patients and reveal that microbiota composition correlates with immunotherapy response. By integrating microbiome profiling into cancer prognosis and treatment selection, this study offers a novel strategy for precision oncology, advancing microbial biomarkers for risk assessment, drug selection, and personalized immunotherapy.  \nKEYWORDS tumor microbiome, TME, tumorigenesis, metastasis, drug response, immunotherapy  \nM icrobial communities inhabit diverse niches within the human body, including the  \ngut, skin, and even tumor tissues, where they play crucial roles in modulating the host immune system and influencing responses to therapies (1–4) . Recent advancements in detecting technologies and in-depth exploration of the tumor microbiome have revealed differences in microbiota composition and abundance between tumor and normal tissues (5–7) . Special microbiota are enriched in certain tumors compared to normal tissues, such as Bacteroidetes, Firmicutes, and Fusobacteria in esophageal adenocarcinoma (8, 9); Chlamydia, Mycoplasma, Acinetobacter, and Brucella in ovarian  \nEditor Qi Su, The Chinese University of Hong Kong, Hong Kong, Hong Kong  \nAddress correspondence to Yue Chen, [yuechen@tust.edu.cn](yuechen@tust.edu.cn), or Xingzhong Liu, [liuxz@nankai.edu.cn](liuxz@nankai.edu.cn).  \nauthors declare conflicts of interest  \ncancers (10); Atopobium sp. and Porphyromonas [sp. in](sp. in) endometrial cancers (11); and Gammaproteobacteria in pancreatic cancers (12) . These distinct microbiome signatures across various cancers suggest their potential as diagnosis and prognosis indicators, complementing traditional gene-based prognostic models (13) .  \nIntratumoral microorganisms have a significant influence on tumor metasta","cbCaiaiOoRh8L0XO","https://ap.wps.com/l/cbCaiaiOoRh8L0XO","pdf",4630082,15,"English","# Abstract and Importance\n## Core microbiota discovery and risk-score model\n## Prognostic links: metastasis signaling and outcomes\n## Drug sensitivity and immunotherapy response","[{\"question\":\"What core microbiota did the study identify in gastrointestinal cancers?\",\"answer\":\"The study identifies a core microbiota composed of 15 bacterial genera associated with patient prognosis across six gastrointestinal cancer types.\"},{\"question\":\"How does the microbiota-based risk-score model work and what does it predict?\",\"answer\":\"Using bacterial abundance, the model calculates a risk score. High-risk scores predict poorer prognosis, enhanced metastatic potential, and pathway activation including EMT, angiogenesis, KRAS, and TGFβ signaling.\"},{\"question\":\"Which treatments did the model suggest for high-risk patients, and how did microbiota relate to immunotherapy?\",\"answer\":\"The model predicts sensitivity to XL999 and tandutinib for high-risk patients. It also links microbiota composition to immunotherapy outcomes, with high-risk patients less likely to benefit from immunotherapy.\"}]","Intratumoral core microbiota predicts prognosis and therapeutic response in gastrointestinal cancers | PDF",1790185175,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cccce7d7c0b5beaed78ae23657f1f52.webp",983,1315,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b457c002f9e6b4ef21bd70e47a0aec2c.webp",982,1314,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7740078364504f783110d4a8b3bb7efd.webp",981,1312,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9a458ea99915bf84172bf9930a9f2d1.webp",980,1311]